SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AstraZeneca PLC Release: SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma